Numico a target for pharma companies?

29 May 2001

Numico, the Dutch food group, has dropped a broad hint that it iswilling to listen to merger plans, especially from pharmaceutical firms. The group's chief executive, Hans van der Wielen, named Novartis, American Home Products and Bristol-Myers Squibb in an interview with the Dutch newspaper NRC Handelsblad as potential partners.

No merger talks have been held as yet, but numerous investment bankers have paid Numico a visit to discuss possible link-ups. Mr van der Wielen told the newspaper that if the firm "could form a combination with one of the three.....we would get a world organization."

Numico says it is undervalued

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory



Companies featured in this story

More ones to watch >




Today's issue

Company Spotlight